Empagliflozin + Metformin HCI
Diajard-M (Empaglifozin+Metformin) is a prescription medicine used to: Diabetes Mellitus Type-2
Tell your doctor if you have hypersensitivity to the active substance or to any of the excipients. Or had any previous episode of ketoacidosis.
DOSAGE & ADMINISTRATION:
Take Diajard-M (empagliflozin and metformin) twice daily with meals, with gradual dose escalation to reduce the gastrointestinal side effects due to metformin. Adjust dosing based on effectiveness and tolerability while not exceeding the maximum recommended daily dose of metformin hydrochloride 2000mg and empagliflozin 25mg.
Diabetes Type-2 patients on prescription of a doctor
Patients with history of serious hypersensitivity reaction to empagliflozin or any of the excipients. Patients with severe renal impairment, end-stage renal disease, or dialysis.
The reported adverse events are; hypotension, ketoacidosis, acute kidney injury and impairment in renal function, urosepsis and pyelonephritis, hypoglycemia with concomitant use with insulin and insulin secretagogues, necrotizing fasciitis of the perineum (Fournier’s gangrene), genital mycotic infections, hypersensitivity reactions, increased low-density lipoprotein cholesterol, urinary tract infection (asymptomatic bacteriuria, cystitis), female genital mycotic infection
Diajard-M is presented in 5/500, 5/1000, 12.5/500 or 12.5/1000
Do not store above 30°C,keep in dry place, protect from light
Patient should consult with their physician before taking any medicine.